Page 36 - Jack Weinstein News Today

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous/Miscellaneous Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for

RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous/Miscellaneous06-Oct-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug A...

Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Study Relief Reports that U.S. Collaboration Partner Announced Second Favorable Safety Report for ZYESAMI (RLF-100TM/aviptadil) in NIH

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Scientific publication Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating

In an unusual move, the Second Circuit on Wednesday threw out a late Brooklyn federal judge's four-year prison sentence for a woman who admitted to providing material support to ISIS and violated the terms of her release, calling the term "shockingly low."

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study19.08.2021 / 07:00  Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Critical Care Study in Patients with Life-Threatening COVID-19Geneva, Switzerland...

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19 19.08.2021 / 07:00   Relief Reports...

The Taliban, which for hours had been in the outskirts of Kabul, announced soon after they would move farther into a city gripped by panic.

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Takeover Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita 28.07.2021 / 07:00 Acquisition Expands Scope of Development of Inhaled Formulation of Aviptadil Geneva, Switzerland, July 28, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today...